SIFI > About
Vision & History

Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development, innovation and production have never stopped. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide.

A closer look …
SIFI, the leading Italian ophthalmic company, has been focused on Eye Care since its foundation in 1935, featuring an integrated business model, from research & development to manufacturing and commercialization both in the pharmaceutical and biomedical sectors.

Our mission is to provide ophthalmologists and their patients with a wide range of therapeutic solutions, including  innovative pharmaceuticals, medical devices and nutraceuticals.

SIFI concentrates its R&D and manufacturing in Italy and has commercial subsidiaries in Romania and Mexico. Additionally, SIFI markets its products in more than 20 countries through distributors.

Since June 2015, SIFI is backed by 21 Investimenti, a private equity firm founded by Alessandro Benetton, to support the company’s expansion strategy, which is based on establishing (or acquiring) direct commercial operations in major European markets and expanding its network of international distributors.

OFTAFARMA S.r.l.
Created in 1998 Oftafarma successfully markets SIFI products in the Romanian market, one of the most dynamic in Eastern Europe, with a focus on innovation in ophthalmology.

LABORATORIOS SIFI de México S.A. de C.V.
Founded in 2007, SIFI’s Central American Laboratories mark the beginning of SIFI Group penetration into one of the most promising emerging markets.



share & tag us with
#history #EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate...
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...
 
Manufacturing In the last years SIFI has generated more than 60 patents and secured international alliances worldwide to export its growing portfolio overseas. Our product range spans from state-of-the-art...

On our Social Channels

From our News Center

SIFI to strengthen R&D Pipeline with Pro-Ocular™ containing a neurosteroid with novel dosage delivery system that activates neural signaling to produce endogenous tear film without...
 

 

08 June

Don't miss the SIFI Symposium at the XIX G.I.Vre Italian Group of Vitreoretinal Surgery on treatment of diabetic macular edema presenting three-year data of the "real...
Follow Us!